Published in Exp Mol Pathol on June 01, 2001
Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br J Cancer (2003) 1.33
Keratinocyte apoptosis in epidermal development and disease. J Invest Dermatol (2006) 1.28
UVB-induced apoptosis drives clonal expansion during skin tumor development. Carcinogenesis (2004) 1.13
Survivin expression in oral squamous cell carcinoma. Br J Cancer (2003) 1.06
Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma. J Cancer Res Clin Oncol (2008) 0.85
Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling. Br J Cancer (2013) 0.83
Epigenetic mechanisms in oral carcinogenesis. Future Oncol (2012) 0.83
Expression of nuclear survivin in normal skin and squamous cell carcinoma: a possible role in tumour invasion. Br J Cancer (2013) 0.80
Survivin expression correlates with nodal metastasis in T1-T2 squamous cell carcinoma of the tongue. Eur Arch Otorhinolaryngol (2014) 0.77
Does Notch play a tumor suppressor role across diverse squamous cell carcinomas? Cancer Med (2016) 0.77
GNRs@SiO2-FA in combination with radiotherapy induces the apoptosis of HepG2 cells by modulating the expression of apoptosis-related proteins. Int J Mol Med (2015) 0.75
Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma. Cell Mol Biol Lett (2017) 0.75
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med (1997) 12.65
Control of apoptosis and mitotic spindle checkpoint by survivin. Nature (1998) 8.60
Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat Cell Biol (1999) 4.11
Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res (1998) 3.63
Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc Natl Acad Sci U S A (2000) 3.44
Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J Biol Chem (2000) 3.30
Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol (1998) 2.64
Transcriptional analysis of human survivin gene expression. Biochem J (1999) 2.39
Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res (1998) 2.38
Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem (1998) 2.27
Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood (2000) 2.23
Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway. Cell (1993) 2.22
Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. J Invest Dermatol (1999) 2.21
Control of apoptosis during angiogenesis by survivin expression in endothelial cells. Am J Pathol (2000) 2.10
Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet (1998) 2.08
Concordance between telepathologic diagnosis and conventional histopathologic diagnosis: a multiobserver store-and-forward study on 20 skin specimens. Arch Dermatol (2002) 2.07
Cancer gene therapy using a survivin mutant adenovirus. J Clin Invest (2001) 2.05
RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Clin Cancer Res (1998) 2.00
Odontogenic myxoma of the jaws: a clinical, radiologic, immunohistochemical, and ultrastructural study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1996) 1.91
The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression. Cancer Res (1999) 1.89
Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc Natl Acad Sci U S A (2001) 1.89
Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions. Oncogene (2009) 1.87
Nevoid basal cell carcinoma syndrome. Clinical findings in 37 Italian affected individuals. Clin Genet (1999) 1.83
Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway. J Biol Chem (1999) 1.82
Crystal structure and mutagenic analysis of the inhibitor-of-apoptosis protein survivin. Mol Cell (2000) 1.70
Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. J Clin Oncol (1996) 1.67
Early diagnosis of nevoid basal cell carcinoma syndrome. J Am Dent Assoc (1999) 1.67
Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53. J Clin Invest (2001) 1.64
Factor Xa as an interface between coagulation and inflammation. Molecular mimicry of factor Xa association with effector cell protease receptor-1 induces acute inflammation in vivo. J Clin Invest (1997) 1.61
Regulation of survivin expression by IGF-1/mTOR signaling. Oncogene (2006) 1.59
Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med (1999) 1.58
Cytokine-regulated expression of survivin in myeloid leukemia. Blood (2001) 1.56
Expression and prognostic significance of survivin in de novo acute myeloid leukaemia. Br J Haematol (2000) 1.56
Endothelial cell activation by leukocyte microparticles. J Immunol (1998) 1.49
Granular cell ameloblastoma: a case report with histochemical findings. Eur J Cancer B Oral Oncol (1996) 1.49
In vivo immunosuppression by targeting a novel protease receptor. Nature (1996) 1.42
Silencing the MET oncogene leads to regression of experimental tumors and metastases. Oncogene (2007) 1.42
Hypertensive left ventricular remodeling and ACE-gene polymorphism. Cardiovasc Res (1999) 1.41
Regulation of leukocyte-endothelium interaction and leukocyte transendothelial migration by intercellular adhesion molecule 1-fibrinogen recognition. Proc Natl Acad Sci U S A (1995) 1.39
Morphometric analysis of AgNORs in uveal malignant melanoma. Anal Quant Cytol Histol (1998) 1.39
A primary, lateral-cervical medullary thyroid carcinoma: a case report. J Clin Endocrinol Metab (1996) 1.38
High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant. J Clin Endocrinol Metab (1999) 1.37
Drug resistance in melanoma: mechanisms, apoptosis, and new potential therapeutic targets. Cancer Metastasis Rev (2001) 1.36
Insulin-like growth factor-I stimulates the growth of rat thyroid cells in culture and synergizes the stimulation of DNA synthesis induced by TSH and Graves'-IgG. Endocrinology (1986) 1.33
Transcatheter closure of persistent ductus arteriosus with the Amplatzer duct occluder in very young symptomatic children. Heart (2004) 1.31
Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. Lab Invest (1999) 1.31
The treatment of oral aphthous ulceration or erosive lichen planus with topical clobetasol propionate in three preparations: a clinical and pilot study on 54 patients. J Oral Pathol Med (2001) 1.29
The relationship of growth and adenylate cyclase activity in cultured thyroid cells: separate bioeffects of thyrotropin. Endocrinology (1983) 1.29
Cell division regulation by BIR1, a member of the inhibitor of apoptosis family in yeast. J Biol Chem (2000) 1.29
Clinically equivocal melanocytic skin lesions with features of regression: a dermoscopic-pathological study. Br J Dermatol (2004) 1.27
Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. Am J Pathol (2001) 1.27
Role of FK506-binding protein 51 in the control of apoptosis of irradiated melanoma cells. Cell Death Differ (2010) 1.26
Block in the expression of differentiation markers of rat thyroid epithelial cells by transformation with Kirsten murine sarcoma virus. Cancer Res (1982) 1.25
MRP8, a new member of ABC transporter superfamily, identified by EST database mining and gene prediction program, is highly expressed in breast cancer. Mol Med (2001) 1.25
Urine detection of survivin and diagnosis of bladder cancer. JAMA (2001) 1.23
Molecular identification of a novel fibrinogen binding site on the first domain of ICAM-1 regulating leukocyte-endothelium bridging. J Biol Chem (1997) 1.23
Binding of fibrinogen to human monocytes. J Clin Invest (1986) 1.20
A rare case of fibrosarcoma of the jaws in a 4-year-old male. Oral Oncol (1998) 1.20
A functional analysis of a natural variant of intercellular adhesion molecule-1 (ICAM-1Kilifi). Hum Mol Genet (2000) 1.19
A set of miRNAs participates in the cellular senescence program in human diploid fibroblasts. Cell Death Differ (2011) 1.19
Differential ligand binding specificities of recombinant CD11b/CD18 integrin I-domain. J Biol Chem (1994) 1.18
PATZ1 gene has a critical role in the spermatogenesis and testicular tumours. J Pathol (2008) 1.17
Angiogenesis and lymphangiogenesis in bronchial asthma. Allergy (2010) 1.17
Survivin does not inhibit caspase-3 activity. Blood (2000) 1.15
Diagnostic and prognostic implications of the World Health Organization classification of neuroendocrine tumors. J Endocrinol Invest (2008) 1.14
Accelerated bone mass senescence after hematopoietic stem cell transplantation. Transl Med UniSa (2013) 1.13
Recurrent varicose veins of the lower limbs after surgery. Role of surgical technique (stripping vs. CHIVA) and surgeon's experience. G Chir (2012) 1.13
Survivin, a potential early predictor of tumor progression in the oral mucosa. J Dent Res (2003) 1.13
Interleukin-11 up-regulates survivin expression in endothelial cells through a signal transducer and activator of transcription-3 pathway. Lab Invest (2001) 1.13
In vitro studies on selective inhibition of tumor cell growth by seminal ribonuclease. Cancer Res (1980) 1.11
Expression of cell cycle and apoptosis-related proteins in sporadic odontogenic keratocysts and odontogenic keratocysts associated with the nevoid basal cell carcinoma syndrome. J Dent Res (1999) 1.08
A Troubling Diagnosis of Verrucous Squamous Cell Carcinoma ("the Bad Kind" of Keratosis) and the Need of Clinical and Pathological Correlations: A Review of the Literature with a Case Report. J Skin Cancer (2010) 1.08
Number II. Pemphigus vulgaris. Oral Dis (2005) 1.08
An anomalous positron abundance in cosmic rays with energies 1.5-100 GeV. Nature (2009) 1.07
FK506 binding protein 51 positively regulates melanoma stemness and metastatic potential. Cell Death Dis (2013) 1.06
Metacognition as a mediator of the effects of impairments in neurocognition on social function in schizophrenia spectrum disorders. Acta Psychiatr Scand (2010) 1.06
Odontogenic myxoma: report of a case with peculiar features. J Oral Maxillofac Surg (1991) 1.06
Tricholemmal carcinoma: a study of seven cases. J Cutan Pathol (1992) 1.06
Survivin expression in oral squamous cell carcinoma. Br J Cancer (2003) 1.06